NZCity NewsLinks -

Finance

3 May 2024

Search

Rua Bioscience Expands International Reach to Canada.
Tairawhiti, New Zealand – Rua Bioscience, a leading innovator in medicinal cannabis cultivation, is pleased to announce a ground-breaking agreement with Canada’s Apollo Green

RUA - Launch of first product in Australia
Rua Bioscience positioned for growth, establishing collaborative networks and seizing opportunity in the booming Australian cannabis market

RUA - Australian Licences received
Rua Bioscience has received the required Licences to begin wholesale and trade activities of Rua branded medicinal cannabis products in Australia. In conjunction with its distributor in Australia, Rua plans to launch a range of products in Australia in Q3

RUA - Announcement of Director Appointment and Retirement
Rua Bioscience (NZX:RUA) today announces the appointment of Tony Barclay as an Independent Non-Executive Director

Rua completes first step to Polish market entry
Rua Bioscience (NZX:RUA) is pleased to announce that its first medicinal cannabis dossier for the Polish market has now been submitted to the regulatory authority responsible for licencing cannabis-based medicines in Poland

Rua Bioscience ASM Presentation and Speeches
The attached ‘Presentation Slides’ and ‘Chairman’s and Managing Director’s Commentary’ will be presented at the Rua Bioscience Annual Shareholders Meeting

Rua announces closing date for Director Nominations 2022
Rua Bioscience Limited (NZX: RUA) advises the closing date for Director nominations is 5:00pm NZST on Tuesday 6 September 2022

Rua Bioscience CEO Rob Mitchell to retire
Rua Bioscience (NZX:RUA) Chief Executive Officer Rob Mitchell has advised the Board of his intention to retire from his role effective from 1 September 2022

RUA - Key Appointment of Chief of Sales and Marketing, Australia
Rua Bioscience proudly announce the strategic appointment of Mr. John Sanders as the Chief of Sales and Marketing for Australia, marking a pivotal moment as he becomes the first Australian employee of Rua Bioscience

RUA - Launch of first product in Australia
Rua Bioscience positioned for growth, establishing collaborative networks and seizing opportunity in the booming Australian cannabis market

Rua Launches in Germany
Rua Bioscience (NZX: RUA) has successfully launched its first medicine in Germany. In doing so, the company has become one of the first medicinal cannabis companies in New Zealand to introduce a branded product

Rua Bioscience CFO Hamish White Resigns
Rua Bioscience (NZX: RUA) today announced the resignation of Chief Financial Officer, Hamish White, effective 30 June 2023. The company is incredibly grateful for the contributions he has made during his tenure and wishes him well in his future endeavours

Rua Bioscience Confirms First International Order
Rua Bioscience Limited (NZX: RUA) formally announced today that it has received its first order via its German distributor Nimbus Health, marking a significant commercial milestone for the export-focused company

RUA - Results of 2022 Shareholders Meeting
Rua Bioscience (NZX: RUA) advises that all resolutions put to its hybrid Annual Shareholders’ Meeting (held online and in Gisborne today) were passed by Shareholders

RUA - Significant Headway Made with Trans-Tasman Partnership
Rua Bioscience’s cultivation partnership with Australian-based Cann Group is making significant headway; the two companies achieving key milestones this week

Rua Bioscience CEO Rob Mitchell to retire
Rob Mitchell will retire from his role as chief executive of medicinal cannabis company Rua Bioscience.Mitchell guided Rua's entry onto the New Zealand Stock Exchange (NZX) in October 2020. Rua chair Trevor Burt hailed Mitchell's...